RNA binding protein DDX5 restricts RORγt<sup>+</sup> T<sub>reg</sub> suppressor function to promote intestine inflammation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36724232.
- Also identified by DOI 10.1126/sciadv.add6165 and PMC identifier 9891705.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Retinoid-related orphan receptor (RAR) gamma (RORγt)-expressing regulatory T cells (RORγt<sup>+</sup> T<sub>regs</sub>) play pivotal roles in preventing T cell hyperactivation and maintaining tissue homeostasis, in part by secreting the anti-inflammation cytokine interleukin-10 (IL-10). Here, we report that hypoxia-induced factor 1α (HIF1α) is the master transcription factor for <i>Il10</i> in RORγt<sup>+</sup> T<sub>regs</sub>. This critical anti-inflammatory pathway is negatively regulated by an RNA binding protein DEAD box helicase 5 (DDX5). As a transcriptional corepressor, DDX5 restricts the expression of HIF1α and its downstream target gene <i>Il10</i> in RORγt<sup>+</sup> T<sub>regs</sub>. T cell-specific <i>Ddx5</i> knockout (DDX5<sup>ΔT</sup>) mice have augmented RORγt<sup>+</sup> T<sub>reg</sub> suppressor activities and are better protected from intestinal inflammation. Genetic ablation or pharmacologic inhibition of HIF1α restores enteropathy susceptibility in DDX5<sup>ΔT</sup> mice. The DDX5-HIF1α-IL-10 pathway is conserved in mice and humans. These findings reveal potential therapeutic targets for intestinal inflammatory diseases.
Medical subject headings
- Interleukin-10
- Nuclear Receptor Subfamily 1, Group F, Member 3